Visual Dysfunction and Structural Correlates in Sorsby Fundus Dystrophy.

Bruch's membrane Dark adaptation Fundus-controlled perimetry Microperimetry Outcome measures Sorsby Fundus Dystrophy

Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
02 2022
Historique:
received: 18 04 2021
revised: 26 07 2021
accepted: 27 07 2021
pubmed: 6 8 2021
medline: 11 3 2022
entrez: 5 8 2021
Statut: ppublish

Résumé

To elucidate morphological determinants of rod and cone dysfunction in Sorsby fundus dystrophy (SFD), and to systematically compare visual function tests for interventional trials. Prospective cross-sectional study. Patients with SFD (n = 16) and controls (n = 20) underwent visual function testing (best-corrected visual acuity [BCVA] and low luminance visual acuity [LLVA], contrast sensitivity, mesopic and dark-adapted (DA) fundus-controlled perimetry [FCP], rod-mediated dark adaptation [RMDA]), and multimodal imaging. Vision-related quality of life was evaluated. FCP and RMDA thresholds were analyzed using mixed models and structure-function correlation using machine learning (ML). Longitudinal data of 1 patient with high-dose vitamin A supplementation were available. Although photopic BCVA was normative in SFD, LLVA was impaired (0.30 LogMAR [0.20; 0.45] vs 0.20 LogMAR [0.03; 0.28], P < .05). Scotopic visual function exhibited a delayed rod-intercept time (21 minutes [12.15; 21] vs 4.05 minutes [3.22; 5.36], P < .001), and marked DA cyan mean sensitivity loss (-11.80 dB [-3.47; -19.85]), paralleled by a reduced vision-related quality of life. ML-based structure-function correlation allowed prediction of mesopic, DA cyan, and red sensitivity with high accuracy (cross-validated mean absolute error: 4.36, 7.77, and 5.31 dB, respectively), whereas RMDA could be slowed even in the absence of fundus alterations on multimodal imaging. After high-dose vitamin A supplementation, RMDA and DA thresholds improved markedly. Patients with SFD exhibit severely impaired scotopic visual function even in the absence of funduscopic alterations on multimodal imaging. In contrast to BCVA, scotopic visual function tests are suitable to quantify dysfunction in the early stages. Improvement of scotopic dysfunction after (off-label) high-dose vitamin A intake, as observed in one patient in our study, is compatible with the hypothesized local deficiency of vitamin A secondary to Bruch's membrane alterations.

Identifiants

pubmed: 34352251
pii: S0002-9394(21)00399-8
doi: 10.1016/j.ajo.2021.07.032
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-284

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Kristin Raming (K)

From the Department of Ophthalmology (K.R., J.B., P.H., F.G.H., M.P., K.H.), University of Bonn, Bonn, Germany; Center for Rare Diseases (K.R., P.H., F.G.H., K.H.), University of Bonn, Bonn, Germany.

Martin Gliem (M)

Boehringer Ingelheim GmbH (M.G.), Ingelheim am Rhein, Germany.

Peter Charbel Issa (P)

Oxford Eye Hospital (P.C.I., J.B.,), Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Nuffield Laboratory of Ophthalmology (P.C.I., J.B.), Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.

Johannes Birtel (J)

From the Department of Ophthalmology (K.R., J.B., P.H., F.G.H., M.P., K.H.), University of Bonn, Bonn, Germany; Oxford Eye Hospital (P.C.I., J.B.,), Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Nuffield Laboratory of Ophthalmology (P.C.I., J.B.), Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.

Philipp Herrmann (P)

From the Department of Ophthalmology (K.R., J.B., P.H., F.G.H., M.P., K.H.), University of Bonn, Bonn, Germany; Center for Rare Diseases (K.R., P.H., F.G.H., K.H.), University of Bonn, Bonn, Germany.

Frank G Holz (FG)

From the Department of Ophthalmology (K.R., J.B., P.H., F.G.H., M.P., K.H.), University of Bonn, Bonn, Germany; Center for Rare Diseases (K.R., P.H., F.G.H., K.H.), University of Bonn, Bonn, Germany.

Maximilian Pfau (M)

From the Department of Ophthalmology (K.R., J.B., P.H., F.G.H., M.P., K.H.), University of Bonn, Bonn, Germany; Ophthalmic Genetics and Visual Function Branch (M.P.), National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.

Kristina Hess (K)

From the Department of Ophthalmology (K.R., J.B., P.H., F.G.H., M.P., K.H.), University of Bonn, Bonn, Germany; Center for Rare Diseases (K.R., P.H., F.G.H., K.H.), University of Bonn, Bonn, Germany; Division of Epidemiology and Clinical Applications (K.H.), National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: Kristina.hess@ukbonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH